11 Feb 2019 by AXXELIS
How can pharmaceutical companies adapt to a digital environment?
Rising Physician Dissatisfaction in Europe Signals an Urgent Need for Change
In the two years since we last surveyed physicians working on the front line of European healthcare, their discontent has risen to an alarming level. Many say they would not recommend their hospital as a place to work or to receive care. Physicians and surgeons also have grown increasingly dissatisfied with pharma companies and medtech manufacturers over the past two years…
AI Drug Discovery Company Raises €23M and Signs with Roche
Oxford-based Exscientia has closed a €23M ($26M) Series B round and announced a partnership with Roche worth up to €60M.
Exscientia has developed an artificial intelligence platform to boost drug discovery in pharma and biotech. “We can reduce at least 4- to 5-fold the time and cost of drug discovery as compared to the industry standard,” Andrew Hopkins, CEO of Exscientia, told me.